BrainsWay
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BrainsWay and other ETFs, options, and stocks.About BWAY
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain.
CEOHadar Levy
CEOHadar Levy
Employees120
Employees120
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2003
Founded2003
Employees120
Employees120
BWAY Key Statistics
Market cap458.67M
Market cap458.67M
Price-Earnings ratio72.51
Price-Earnings ratio72.51
Dividend yield—
Dividend yield—
Average volume140.88K
Average volume140.88K
High today$23.88
High today$23.88
Low today$23.30
Low today$23.30
Open price$23.58
Open price$23.58
Volume91.67K
Volume91.67K
52 Week high$24.84
52 Week high$24.84
52 Week low$7.84
52 Week low$7.84
BWAY News
TipRanks 2d
Brainsway announces U.S. FDA granted PMA for Neurolief’s ProlivRx systemBrainsWay (BWAY) announced that the U.S. Food and Drug Administration, FDA, has granted Premarket Approval, PMA, for Neurolief’s ProlivRx system, a Class III de...